MedTrace Logo

Cardiovascular Imaging and Biomarker Analyses (CIBER)

NCT03074253 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-10-31

No results posted yet for this study

Summary

"Cardiovascular Imaging and Biomarker Analyses (CIBER)" is a single-center, prospective and observational study evaluating the expression of novel biomarkers in patients undergoing cardiacvascular imaging within clinical routine care. It is aimed to evaluate associations with biomarker expressions with ascertained cardiac imaging parameters.

Conditions

Interventions

DIAGNOSTIC_TEST

Echocardiography

Patients are undergoing echocardiography

DIAGNOSTIC_TEST

magnetic resonance imaging

Patients are undergoing magnetic resonance imaging

DIAGNOSTIC_TEST

computed tomography

Patients are undergoing computed tomography

DIAGNOSTIC_TEST

blood withdrawl

Peripheral blood samples are being collected from all patients

Sponsors & Collaborators

  • Universitätsmedizin Mannheim

    lead OTHER

Principal Investigators

  • Ibrahim Akin, Prof. Dr. · University Medical Center Mannheim

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-01
Primary Completion
2020-07-01
Completion
2021-07-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03074253 on ClinicalTrials.gov